from FDA,2023.09
Exkivity reduces the growth of non-small cell lung cancer by binding to and inhibiting EGFR exon 20 insertion mutations.What interactions can occur with other medicationsExkivity m···【more】
Article source:Lucius LaosRelease date:2024-08-09Recommended:141
Exkivity works by binding to and blocking EGFR exon 20 insertion mutations, which helps to slow the growth of cancer cells.Which drugs interact with ExkivityExkivity may interact w···【more】
Article source:Lucius LaosRelease date:2024-08-09Recommended:153
Exkivity was granted accelerated FDA approval in 2021 based on results from the clinical trial NCT02716116. It is used with the Oncomine Dx Target Test, which identifies patients w···【more】
Article source:Lucius LaosRelease date:2024-08-09Recommended:163
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: